FREE E-BOOK

The BIG PICTURE

A Young Woman, a Camera, an Uncompromising Ethic

June 13-17

Download your copy now at

https://www.amazon.com/-/e/B003DS6LEU

Young, talented, ambitious, Freyja Brynjarrson’s a photographer struggling to crash the art establishment, the challenges presented by her family, and keep true to her uncompromising ethic.

Fate places her on the front line of a political demonstration where soldiers open fire on civilians. She photographs death for the first time and the intensity makes everything she’s done previously in art and life seem inconsequential.

The current government is concerned these highly charged images could sway the voters against them. With a closely contested election only three days away, they’re doing whatever they can to attempt to suppress their publication. But someone far more unscrupulous than government spin-doctors also wants these images destroyed.

Gunnar Brynjarrson, Freyja’s eldest brother is the head of an illegal narcotics empire. He’s concerned about the opposition party’s platform to decriminalize drugs. His sister’s photographs could influence the outcome of a close election and put his business in jeopardy.

As events unfold, Freyja slowly becomes aware of the far-reaching impact the billions of narco dollars have on the government, the economy, friends, family and even herself. Something insidious has infected society and like a superbug, it’s resilient, opportunistic and appears as a mutation in the most unexpected places.

Freyja refuses to compromise and is intolerant and unforgiving of those who succumb to this evil or are complicit in their acceptance of it. If she stays at home, she’s afraid she’ll be infected and never attain success on her own terms. She takes an assignment with an international agency photographing the chaos and casualties of Mexico’s drug war. Freyja soon discovers she’s shot only one frame of ‘the big picture’.

The Big Picture focuses on dramatic action, zooms in on political intrigue, and takes a candid snapshot of modern romance. The plot also reveals how narco dollars, overtly and covertly, influence every level of our lives; the wars we fight, the governments we elect, the impact on healthcare, and most importantly and tragically, our personal relationships.

"The plot of The Big Picture, with its twists and reversals of fortune, ...is imaginative and fast moving...extremely compelling. ....characters are diverse, well developed, and real... ...imagery is powerful and fresh. The book is an excellent read and pausing to experience some of the imagery makes it even better."

"The Big Picture is ...a thought-provoking novel that is smartly written with genuine emotional, no holds barred dialogue, and events that will punch you in the heart. - This book was a gem to read and an interesting one at that."

"...a journey of self discovery... a coming-of-age, social thriller... focused on key ethical questions... a creative solution to expose the links of social problems."
Tom Pope - for Bookpleasures

"I like the plot and the plotters...Arni's sense of humor and the dynamics in the Brynjarsson family...Gunnar the druglord, BB the addict, Arni the hedonist, Giordana who rationalizes and Freyja who wants to fight. I like the love story, too. Freyja and Marty with their differences and similarities make a good couple.
... (there are) moral issues in The Big Picture. The drugs, corruption, the way people with beliefs and principles slowly drop them in the treadmill of politics and re-elections. What drug money does to each of the Brynjarssons. Freyja's ethics against Gunnar's power."
- C. Widmann, Goodreads Review

Imaginative and fast moving...extremely compelling...will punch you in the heart.
5 STARS - Readers' Favorite Book Reviews

This is a fascinating novel...adventure, excitement, drug cartels, family issues, romance...themes that are important and questions we sometimes need to ask ourselves.

Judge's commentary - 2nd Annual Writer's Digest Self-Published eBook Awards

CLICK HERE TO

TO WATCH PROMOTIONAL VIDEO

#books #bookworm #twitterbooks

#newbooksnetwork #goodreads #amreading #readingcommunity

#booklovers #newfiction #readers #read

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs.

What the Autoinjectors Market Looks Like?

MarketsandMarkets forecasts Autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2%. North America to witness the highest market growth during the forecast period.

Growth in the global autoinjectors market is mainly driven by factors such as the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements in autoinjector devices. The patent expiry of biologics in the coming years is also expected to provide growth opportunities for players in the autoinjectors market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724

What Drives the Autoinjectors Market?

The growth of the global market for Autoinjectors Market is primarily influenced by the following factors:

• Growing Prevalence of Targeted Therapies
• Rising Incidence of Anaphylaxis
• Increasing Number of Regulatory Approvals
• Availability of Generic Versions of Autoinjectors
• Favorable Reimbursements and Government Support
• Technological Advancements and Design Development

Disposable autoinjectors are the most-preferred autoinjectors due to their ease of use and the presence of a built-in glass syringe (eliminates the need for manually loading the glass syringe), which makes it more convenient for patients with reduced dexterity or visual impairments.

A majority of autoinjectors are used for self-administration of drugs and are rarely recommended for hospital use to avoid the risk of infection due to use on multiple patients. This is a major factor in driving the market growth. Other factors such as the growing prevalence of chronic diseases and technological advancements are also boosting this market segment.

Recent Developments :

• In 2018, Abbvie and Samsung Bioepis signed a licensing agreement to launch Humira biosimilar in Europe.
• In 2018, Amgen collaborated with Simcere to co-develop and commercialize biosimilars in China.
• In 2018, Haselmeier partnered with Common Sensing to develop self-monitoring injector platforms, which will help patients to record the time and amount of every dose.
• In 2017, Ypsomed opened a new manufacturing facility in Solothurn (Switzerland). This new facility will focus on the production of injection systems.
• In 2017, Johnson & Johnson received FDA approval of SIMPONI for the treatment of adults with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS).

Geographical growth scenario of Autoinjectors Market :
The large share of the North American autoinjectors market can primarily be attributed to the rising prevalence of autoimmune and chronic diseases, increasing prevalence of anaphylaxis, and the increasing number of FDA approvals in the region.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

Leading market players and strategies adopted

The prominent players in the Autoinjectors market are SHL Group, Becton Dickinson and Company, Ypsomed, Owen Mumford, Haselmeier

Critical questions the report answers:

• Which are the most significant revenue-generating regions for the market?
• What are the significant upcoming trends in the market?
• How will the market drivers, restraints, and future opportunities affect the market dynamics?
• Which end-user segment is expected to witness maximum growth opportunities during the forecast period?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst